Literature DB >> 8259678

Immunodominant antigenic regions in a structural protein of the hepatitis E virus.

M O Favorov, D L Jue, T K Hine, H A Fields.   

Abstract

Using a set of 11 synthetic peptides containing regions of the polypeptide encoded by open reading frame 2 (ORF2) of the hepatitis E virus (HEV) genomic RNA, two immunodominant regions were found. One region is located at position 546-580 amino acids (aa). Another very strong immunodominant region was identified at position 394-470 aa. Five peptides spanning this region were found to have antigenic reactivity. One of these 5 peptides demonstrated specific reactivity with 81% of sera obtained from HEV-infected patients. To elucidate the antigenic structure of this region in fine detail, an additional set of 35 overlapped 20-mer peptides spanning the region 388-493 aa was synthesized. Two subregions with very strong antigenic reactivity, one located around position 420-440 aa and another around 450-460 aa, were identified. Thus, in addition to the strong epitope(s) in the C-terminal region of the ORF2 protein previously identified, at least two immunodominant regions were found at positions 394-470 and 546-580 aa.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8259678     DOI: 10.1006/viro.1994.1048

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  16 in total

1.  Identification of immunodominant and conformational epitopes in the capsid protein of hepatitis E virus by using monoclonal antibodies.

Authors:  M A Riddell; F Li; D A Anderson
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Expression, characterization, and immunoreactivities of a soluble hepatitis E virus putative capsid protein species expressed in insect cells.

Authors:  Y Zhang; P McAtee; P O Yarbough; A W Tam; T Fuerst
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

Review 3.  Lessons learned from successful human vaccines: Delineating key epitopes by dissecting the capsid proteins.

Authors:  Xiao Zhang; Lu Xin; Shaowei Li; Mujin Fang; Jun Zhang; Ningshao Xia; Qinjian Zhao
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

4.  Dynamics of 8G12 competitive antibody in "prime-boost" vaccination of Hepatitis E vaccine.

Authors:  Xing Wu; Pan Chen; Huijuan Lin; Yao Su; Xiaotian Hao; Yufeng Cao; Li Li; Fengcai Zhu; Zhenglun Liang
Journal:  Hum Vaccin Immunother       Date:  2017-03-08       Impact factor: 3.452

5.  The 41-amino-acid C-terminal region of the hepatitis E virus ORF3 protein interacts with bikunin, a kunitz-type serine protease inhibitor.

Authors:  Shweta Tyagi; Milan Surjit; Sunil K Lal
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

6.  Detection of sporadic cases of hepatitis E virus (HEV) infection in China using immunoassays based on recombinant open reading frame 2 and 3 polypeptides from HEV genotype 4.

Authors:  Y Wang; H Zhang; Z Li; W Gu; H Lan; W Hao; R Ling; H Li; T J Harrison
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

7.  Self-association and mapping of the interaction domain of hepatitis E virus ORF3 protein.

Authors:  S Tyagi; S Jameel; S K Lal
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

8.  The ORF2 protein of hepatitis E virus binds the 5' region of viral RNA.

Authors:  Milan Surjit; Shahid Jameel; Sunil K Lal
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

9.  Expression in animal cells and characterization of the hepatitis E virus structural proteins.

Authors:  S Jameel; M Zafrullah; M H Ozdener; S K Panda
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

10.  Screening of specific diagnostic peptides of swine hepatitis E virus.

Authors:  Kai Zhao; Qiwen Liu; Ruisong Yu; Zhen Li; Jianyue Li; Hong Zhu; Xiao Wu; Furong Tan; Jinbin Wang; Xueming Tang
Journal:  Virol J       Date:  2009-11-04       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.